Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
about
Vascular endothelial dysfunction and pharmacological treatmentRole of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heartEffects of short-term treadmill exercise training or growth hormone supplementation on diastolic function and exercise tolerance in old ratsInfusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritisAddressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus.Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat.Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis.Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated ratsAngiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.Targeting platelets for prevention and treatment of cardiovascular disease.The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmiasHigh glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCsAgonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.New angiotensins.Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomilPortal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.Angiotensin-[1-12] interacts with angiotensin type I receptorsIdentification of Cofilin-1 Induces G0/G1 Arrest and Autophagy in Angiotensin-(1-7)-treated Human Aortic Endothelial Cells from iTRAQ Quantitative Proteomics.Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen.Endothelial Dysfunction and Hypertension.Long-term neprilysin inhibition - implications for ARNIs.Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats.Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension in rats.Renin angiotensin system deregulation as renal cancer risk factor.The effects of angiotensin-(1-7) on the exchanger NHE3 and on [Ca2+]i in the proximal tubules of spontaneously hypertensive rats.Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.Investigational drugs for diabetic nephropathy
P2860
Q26774561-E4E3341A-8991-4B6D-A68E-F5F5B7BEC047Q28079603-1D5B7806-0EDE-4CFD-8538-FA875D6BE93FQ30483339-B2218DFE-424E-4510-A9DA-DD7544B20EC5Q33727783-BC316F2E-4F7D-472B-B262-B03E43BD4B0EQ33783689-8DA66855-D80F-4507-A033-AB8E6ED17F0FQ34001678-5327FE06-5AEA-4FFA-9014-0BDB04970D8FQ34150500-571B22ED-BDCC-433C-A5A6-A04A4861F4C5Q34501975-722C2F02-0483-4AD4-8139-8DBA145E5407Q35216408-4708A430-EAF7-421B-B1CB-8828203F7D37Q35606516-EEDB3A80-E4BE-4593-9AA8-E437C921F3C8Q36720577-8A5B4F31-849F-424E-9019-65FC05B64BE1Q37004721-DD3A0F4F-084E-4C22-9B54-BDD783FB5590Q37011175-F53744BC-417F-4BC0-B649-A1AF55B69E0CQ37088267-660C8C41-10C5-45ED-B750-39635DFE7B3EQ37147092-C0EBBA00-D9D8-479A-B573-23E5F2C68663Q37147841-C644A2E0-572B-4239-B0B5-A8AB31F97E14Q37167510-5769C29D-67F3-4B37-9129-B36497B217A2Q37264506-CD2456D9-74A0-4768-BDF1-DA6DA668BB8EQ37296833-C7792747-CC56-4DF4-B651-3C879AEAD748Q37343187-29DF60A7-FEEF-4C5F-A7FC-4F009C4068E8Q37430939-BCD3366A-DDFF-4E71-AB39-2E58068A72C0Q38043998-3B8D6345-F1E1-4E71-9DE9-A36F94034EF7Q38776339-505E7957-3D2E-4B34-AB79-F835D8C76A89Q39038686-6752E7E1-1AFE-4F8A-8823-9CB8ACE5406FQ39430910-370075E6-8F7C-4D8C-9A84-1CDDB9F56D37Q41652967-4A475214-63C1-4331-ACEA-692595A9779FQ41830683-C86B7197-A695-4476-B3EE-58653BB9F545Q42467954-78620AD1-D0FF-4D5E-83A2-C15F832FDC7EQ42950265-837A757D-0D6A-40CE-B9CC-CF9143411D13Q43198447-9735A686-A71B-405D-80DE-AE0DACF937A9Q46617665-EDDA119E-67A2-4FA3-9A9B-3F833AA7FCC9Q46736490-30A120F2-99BA-4A3B-A52B-B36BA639862BQ47094986-5DDE5422-497D-4591-94B1-0A2F4BD7A4D5Q51010079-52686166-ED8F-4466-A64C-1B7713422639Q54517709-DC8B47B7-C31D-45DC-818D-196AEEC0F59BQ57702367-94CBB347-1650-4372-A4A5-638FEE202C21
P2860
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
@en
type
label
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
@en
prefLabel
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
@en
P2860
P1476
Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.
@en
P2093
Aaron J Trask
Carlos M Ferrario
P2860
P304
P356
10.1111/J.1527-3466.2007.00012.X
P577
2007-01-01T00:00:00Z